Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice

Histochemistry and Cell Biology

Volumn 128, Issue 4, 2007, Pages 293-300

  Song, Zhenhu ^a   Ma, Ning ^a   Hayashi, Tatsuya ^a   Gabazza, Esteban C ^a   Sugimura, Yoshiki ^a   Suzuki, Koji ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Immunogold double labeling electron microscopy; Protein C inhibitor; Urinary plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 3; UROKINASE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MICROVILLUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; KIDNEY; MICE; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; PROTEIN C INHIBITOR; URINARY PLASMINOGEN ACTIVATOR;

MURINAE; MUS; MUS MUSCULUS;

EID: 34548669415     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-007-0330-6     Document Type: Article

References (46)

1. Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I (2005) Expression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitro. Reprod Biol Endocrinol 3:7
2. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
3. Asanuma K, Yoshikawa T, Hayashi T, Akita N, Nakagawa N, Hamada Y, Nishioka J, Kamada H, Gabazza EC, Ido M, Uchida A, Suzuki K (2007) Protein C inhibitor inhibits breast cancer cell growth, metastasis, and angiogenesis independently of its protease inhibitory activity. Int J Cancer 121:955-965
4. Brown PA, Wilson HM, Reid FJ, Booth NA, Simpson JG, Morrison L, Power DA, Haites NE (1994) Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. Kidney Int 45:43-47
5. Cao Y, Becker C, Lundwall A, Christensson A, Gadaleanu V, Lilja H, Bjartell A (2003) Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues. Prostate 57:196-204
6. Carlin SM, Resink TJ, Tamm M, Roth M (2005) Urokinase signal transduction and its role in cell migration. FASEB J 19:195-202
7. Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129:307-321
8. Conese M, Blasi F (1995) Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation. Biol Chem Hoppe Seyler 376:143-155
9. Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10:39-49
10. Eddy AA (2002) Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 283:F209-F220
11. Espana F, Estelles A, Fernandez PJ, Gilabert J, Sanchez-Cuenca J, Griffin JH (1993) Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost 70:989-994
12. Florquin S, van den Berg JG, Olszyna DP, Claessen N, Opal SM, Weening JJ, van der Poll T (2001) Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int 59:2054-2061
13. Geiger M, Priglinger U, Griffin JH, Binder BR (1991) Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase. J Biol Chem 266:11851-11857
14. Hayashi T, Suzuki K (1993) Gene organization of human protein C inhibitor, a member of SERPIN family proteins encoded in five exons. Int J Hematol 58:213-224
15. Hayashi T, Nishioka J, Kamada H, Asanuma K, Kondo H, Gabazza EC, Ido M, Suzuki K (2004) Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J Thromb Haemost 2:949-961
16. Hayashi T, Nishioka J, Nakagawa N, Kamada H, Gabazza EC, Kobayashi T, Hattori A, Suzuki K (2007) Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator. J Thromb Haemost 5:1477-1485
17. Kasza A, Petersen HH, Heegaard CW, Oka K, Christensen A, Dubin A, Chan L, Andreasen PA (1997) Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein- receptor-related protein. Eur J Biochem 248:270-281
18. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H (1992) Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 89:1094-1101
19. List K, Jensen ON, Bugge TH, Lund LR, Ploug M, Dano K, Behrendt N (2000) Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice. Biochemistry 39:508-515
20. Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, Stura EA, Menez A (2005) Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J 24:1655-1663
21. Ma N, Ding X, Doi M, Izumi N, Semba R (2004) Cellular and subcellular localization of heme oxygenase-2 in monkey retina. J Neurocytol 33:407-415
22. Marksitzer R, Stief A, Menoud PA, Nagamine Y (1995) Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene. J Biol Chem 270:21833-21838
23. Meijers JC, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, Bouma BN (1988) Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 27:4231-4237
24. Moestrup SK, Nielsen S, Andreasen P, Jorgensen KE, Nykjaer A, Roigaard H, Gliemann J, Christensen EI (1993) Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J Biol Chem 268:16564-16570
25. Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25:450-455
26. Palmieri D, Lee JW, Juliano RL, Church FC (2002) Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells. J Biol Chem 277:40950-40957
27. Petersen LC, Lund LR, Nielsen LS, Dano K, Skriver L (1988) One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem 263:11189-11195
28. Radtke KP, Fernandez JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH (1994) Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 94:2117-2124
29. Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP (2000) Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58:1841-1850
30. Rezaie AR, Cooper ST, Church FC, Esmon CT (1995) Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 270:25336-25339
31. Sappino AP, Huarte J, Vassalli JD, Belin D (1991) Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962-970
32. Schwartz BS, Espana F (1999) Two distinct urokinase-serpin interactions regulate the initiation of cell surface-associated plasminogen activation. J Biol Chem 274:15278-15283
33. Stief TW, Radtke KP, Heimburger N (1987) Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hoppe Seyler 368:1427-1433
34. Stump DC, Thienpont M, Collen D (1986) Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma. J Biol Chem 261:12759-12766
35. Suzuki K (2000) Protein C inhibitor (PAI-3): structure and multi-function. Fibrinol Proteol 14:133-145
36. Suzuki K, Nishioka J, Hashimoto S (1983) Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 258:163-168
37. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S (1984) Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 95:187-195
38. Tanski WJ, Fegley AJ, Roztocil E, Davies MG (2004) Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg 39:214-222
39. Turner RB, Liu L, Sazonova IY, Reed GL (2002) Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. J Biol Chem 277:33068-33074
40. Van Leer C, Stutz M, Haeberli A, Geiser T (2005) Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro. Thromb Haemost 94:1257-1264
41. Vassalli JD, Baccino D, Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100:86-92
42. Vilhardt F, Nielsen M, Sandvig K, van Deurs B (1999) Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells. Mol Biol Cell 10:179-195
43. Wagner SN, Atkinson MJ, Wagner C, Hofler H, Schmitt M, Wilhelm O (1996) Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol 105:53-60
44. Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K (2004) Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 108:516-523
45. Watanabe M, Yano W, Kondo S, Hattori Y, Yamada N, Yanai R, Nishida T (2003) Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci 44:3332-3338
46. Zhai XY, Birn H, Jensen KB, Thomsen JS, Andreasen A, Christensen EI (2003) Digital three-dimensional reconstruction and ultrastructure of the mouse proximal tubule. J Am Soc Nephrol 14:611-619